医学
表皮生长因子受体
免疫组织化学
组织微阵列
靶向治疗
内科学
癌基因
肿瘤科
受体
癌症
癌症研究
细胞周期
作者
Mamoru Hashimoto,Kazutoshi Fujita,Eisuke Tomiyama,Saizo Fujimoto,Shogo Adomi,Eri Banno,Takafumi Minami,Tetsuya Takao,Masahiro Nozawa,Hiroaki Fushimi,Kazuhiro Yoshimura,Norio Nonomura,Hirotsugu Uemura
出处
期刊:Anticancer Research
[Anticancer Research USA Inc.]
日期:2022-12-30
卷期号:43 (1): 167-174
被引量:10
标识
DOI:10.21873/anticanres.16146
摘要
HER2, EGFR, and nectin-4 were highly expressed in UTUC. Combination of HER2-, EGFR-, and nectin-4-targeted therapy may be an effective option for the treatment of patients with UTUC.
科研通智能强力驱动
Strongly Powered by AbleSci AI